New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates—Nrf2 activators and GSK-3 inhibitors

The phosphoinositide 3-kinase pathway

Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621 · see citing works

The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells

Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145 · see citing works

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

Mitochondria, Oxidants, and Aging

Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · see citing works

An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements

Itoh, K., Chiba, T., Takahashi, S., Ishii, T., Igarashi, K., Katoh, Y., Oyake, T., Hayashi, N., Satoh, K., Hatayama, I., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6943 · Cited by 3,999 · see citing works

Ischemic Cell Death in Brain Neurons

Lipton, P. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1431 · Cited by 3,043 · see citing works

Assessing mitochondrial dysfunction in cells

Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,436 · see citing works

A molecular mechanism for the effect of lithium on development.

Klein, P. S., & Melton, D. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8455 · Cited by 2,305 · see citing works

The mesolimbic dopamine reward circuit in depression

Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059 · see citing works

Nrf2:INrf2 (Keap1) signaling in oxidative stress

Kaspar, J. W., Niture, S. K., & Jaiswal, A. K. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.07.035 · Cited by 1,647 · see citing works

Mitochondrial control of apoptosis

Kroemer, G., Zamzami, N., & Susín, S. A. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)80014-x · Cited by 1,492 · see citing works

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus

Smith, M., Makino, S., Květňanský, R., & Post, R. M. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-03-01768.1995 · Cited by 1,429 · see citing works

Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation

Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M., Jin, O., & Woodgett, J. R. (2000) · Nature · doi:10.1038/35017574 · Cited by 1,394 · see citing works

The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy

Lemasters, J. J., Nieminen, A.-L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00112-1 · Cited by 1,387 · see citing works

Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4 + T Cells

O’Shea, J. J., & Paul, W. E. (2010) · Science · doi:10.1126/science.1178334 · Cited by 1,341 · see citing works

Mitochondrial permeability transition pore opening during myocardial reperfusion—a target for cardioprotection

Halestrap, A. P. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00533-9 · Cited by 1,223 · see citing works

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178 · see citing works

A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness

Maes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140 · see citing works

Toll-like receptor–mediated cytokine production is differentially regulated by glycogen synthase kinase 3

Martin, M., Rehani, K., Jope, R. S., & Michalek, S. M. (2005) · Nature Immunology · doi:10.1038/ni1221 · Cited by 1,080 · see citing works

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase 1 gene

Radjendirane, V., & Jaiswal, A. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14960 · Cited by 1,034 · see citing works

Oxidative stress in health and disease: The therapeutic potential of Nrf2 activation

Hybertson, B. M., Gao, B., Bose, S. K., & McCord, J. M. (2011) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.006 · Cited by 1,030 · see citing works

Evidence for an immune response in major depression: A review and hypothesis

Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003 · see citing works

The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis

Hannestad, J., DellaGioia, N., & Bloch, M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.132 · Cited by 914 · see citing works

The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression

Maes, M., Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M., Bob, P., Lerer, B., & Maj, M. (2009) · Metabolic Brain Disease · doi:10.1007/s11011-008-9118-1 · Cited by 894 · see citing works

Biochemical Functions of Coenzyme Q ₁₀

Crane, F. L. (2001) · Journal of the American College of Nutrition · doi:10.1080/07315724.2001.10719063 · Cited by 869 · see citing works

IL-1β is an essential mediator of the antineurogenic and anhedonic effects of stress

Koo, J. W., & Duman, R. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708092105 · Cited by 862 · see citing works

The Phosphatidylinositol 3-Kinase-Akt Pathway Limits Lipopolysaccharide Activation of Signaling Pathways and Expression of Inflammatory Mediators in Human Monocytic Cells

Guha, M., & Mackman, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203298200 · Cited by 799 · see citing works

Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis

Malhotra, D., Portales-Casamar, É., Singh, A., Srivastava, S., Arenillas, D. J., Happel, C., Shyr, C., Wakabayashi, N., Kensler, T. W., Wasserman, W. W., et al. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq212 · Cited by 796 · see citing works

The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794 · see citing works

Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

Shih, A. Y., Johnson, D. A., Wong, G., Kraft, A. D., Jiang, L., Erb, H., Johnson, J. A., & Murphy, T. H. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-08-03394.2003 · Cited by 786 · see citing works

Expression of Nrf2 in Neurodegenerative Diseases

Ramsey, C. P., Glass, C. A., Montgomery, M. B., Lindl, K. A., Ritson, G. P., Chia, L. A., Hamilton, R. L., Chu, C. T., & Jordan-Sciutto, K. L. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31802d6da9 · Cited by 760 · see citing works

A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder

McKinnon, M. C., Yucel, K., Nazarov, A., & MacQueen, G. M. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0905 · Cited by 742 · see citing works

Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse

Baker, D. L., McFarland, K., LAKE, R. W., Shen, H., Tang, X., Toda, S., & Kalivas, P. W. (2003) · Nature Neuroscience · doi:10.1038/nn1069 · Cited by 740 · see citing works

Cytokine Production and Treatment Response in Major Depressive Disorder

Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735 · see citing works

Cellular changes in the postmortem hippocampus in major depression

Stockmeier, C. A., Mahajan, G. J., Konick, L. C., Overholser, J. C., Jurjus, G. J., Meltzer, H. Y., Uylings, H. B. M., Friedman, L., & Rajkowska, G. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.022 · Cited by 732 · see citing works

INCREASED SERUM IL-6 AND IL-1 RECEPTOR ANTAGONIST CONCENTRATIONS IN MAJOR DEPRESSION AND TREATMENT RESISTANT DEPRESSION

Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728 · see citing works

Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments

Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718 · see citing works

The permeability transition pore complex: another view

Halestrap, A. P., McStay, G. P., & Clarke, S. J. (2002) · Biochimie · doi:10.1016/s0300-9084(02)01375-5 · Cited by 709 · see citing works

The new ‘5-HT’ hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression

Maes, M., Leonard, B. E., Myint, A. M., Kubera, M., & Verkerk, R. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.12.017 · Cited by 700 · see citing works

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

Schmidt, H. D., & Duman, R. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282ee2aa8 · Cited by 649 · see citing works

Depression: a case of neuronal life and death?

Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.033 · Cited by 612 · see citing works

The Nrf2–ARE Pathway

Johnson, J. A., Johnson, D. A., Kraft, A. D., Calkins, M. J., Jakel, R. J., Vargas, M. R., & Chen, P. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.036 · Cited by 588 · see citing works

The Origin and Neuronal Function ofIn VivoNonsynaptic Glutamate

Baker, D. L., Xi, Z., Shen, H., Swanson, C. J., & Kalivas, P. W. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-20-09134.2002 · Cited by 584 · see citing works

Mitogen inactivation of glycogen synthase kinase-3β in intact cells via serine 9 phosphorylation

Stambolic, V., & Woodgett, J. R. (1994) · Biochemical Journal · doi:10.1042/bj3030701 · Cited by 581 · see citing works

Structural brain abnormalities in major depressive disorder: a selective review of recent MRI studies

Lorenzetti, V., Allen, N. B., Fornito, A., & Yücel, M. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.11.021 · Cited by 553 · see citing works

Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression

Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.014 · Cited by 544 · see citing works

Nrf2-regulated glutathione recycling independent of biosynthesis is critical for cell survival during oxidative stress

Harvey, C. J., Thimmulappa, R. K., Singh, A., Blake, D. J., Ling, G., Wakabayashi, N., Fujii, J., Myers, A. C., & Biswal, S. S. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.10.040 · Cited by 544 · see citing works

Physiological Significance of Reactive Cysteine Residues of Keap1 in Determining Nrf2 Activity

Yamamoto, T., Suzuki, T., Kobayashi, A., Wakabayashi, J., Maher, J. M., Motohashi, H., & Yamamoto, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01704-07 · Cited by 515 · see citing works

Nrf2 as a novel molecular target for chemoprevention

Lee, J., & Surh, Y. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 514 · see citing works

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

Berk, M., Copolov, D. L., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., & Bush, A. I. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.022 · Cited by 500 · see citing works

Interferon-γ and Tumor Necrosis Factor-α Mediate the Upregulation of Indoleamine 2,3-Dioxygenase and the Induction of Depressive-Like Behavior in Mice in Response to Bacillus Calmette-Guérin

O’Connor, J. C., André, C., Wang, Y., Lawson, M. A., Szegedi, S. S., Lestage, J., Castanon, N., Kelley, K. W., & Dantzer, R. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.5032-08.2009 · Cited by 498 · see citing works

<i>N</i>-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

Dean, O., Giorlando, F., & Berk, M. (2011) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.100057 · Cited by 494 · see citing works

Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research

Stork, C., & Renshaw, P. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001711 · Cited by 486 · see citing works

GSK-3β Acts Upstream of Fyn Kinase in Regulation of Nuclear Export and Degradation of NF-E2 Related Factor 2

Jain, A. K., & Jaiswal, A. K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611336200 · Cited by 484 · see citing works

A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids

Lin, P.-Y., & Su, K.-P. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0712 · Cited by 481 · see citing works

The Transcription Factor Nrf2 Is a Therapeutic Target against Brain Inflammation

Innamorato, N. G., Rojo, A. I., García‐Yagüe, Á. J., Yamamoto, M. P., CEBALLOS, M. L. D., & Cuadrado, A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.680 · Cited by 479 · see citing works

Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

Vargas, M. R., Johnson, D. A., Sirkis, D. W., Messing, A., & Johnson, J. A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4099-08.2008 · Cited by 479 · see citing works

Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients

Edwards, R. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00166-3 · Cited by 470 · see citing works

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors

Khanzode, S. D., Dakhale, G. N., Khanzode, S. S., Saoji, A., & Palasodkar, R. (2003) · Redox Report · doi:10.1179/135100003225003393 · Cited by 458 · see citing works

Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus

Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454 · see citing works

Lowered ω3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients

Maes, M. H. J., Christophe, A. B., Delanghe, J., Altamura, C. A., Neels, H. M., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 452 · see citing works

In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression

Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., & Maes, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.08.026 · Cited by 443 · see citing works

The Mood‐Stabilizing Agent Valproate Inhibits the Activity of Glycogen Synthase Kinase‐3

Chen, G., Huang, L., Jiang, Y., & Manji, H. K. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0721327.x · Cited by 439 · see citing works

Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System

Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., Almerighi, C., Verkerk, R., Meltzer, H., & Maes, M. (2002) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200202000-00014 · Cited by 437 · see citing works

Nrf2-induced antioxidant protection: A promising target to counteract ROS-mediated damage in neurodegenerative disease?

de Vries, H. E., Witte, M. E., Hondius, D., Rozemüller, A. J. M., Drukarch, B., Hoozemans, J. J. M., & van Horssen, J. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.09.001 · Cited by 432 · see citing works

IFN-γ Suppresses IL-10 Production and Synergizes with TLR2 by Regulating GSK3 and CREB/AP-1 Proteins

Hu, X., Paik, P. K., Chen, J., Yarilina, A., Kockeritz, L. K., Lu, T. T., Woodgett, J. R., & Ivashkiv, L. B. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.014 · Cited by 407 · see citing works

Modulation of Nrf2/ARE Pathway by Food Polyphenols: A Nutritional Neuroprotective Strategy for Cognitive and Neurodegenerative Disorders

Scapagnini, G., Vasto, S., Nader, A. G., Caruso, C., Zella, D., & Galvano, F. (2011) · Molecular Neurobiology · doi:10.1007/s12035-011-8181-5 · Cited by 403 · see citing works

Stress activation of glutamate neurotransmission in the prefrontal cortex: implications for dopamine-associated psychiatric disorders

Moghaddam, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01362-2 · Cited by 392 · see citing works

Mitochondrial dysfunction in bipolar disorder

Kato, T., & Kato, N. (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.020305.x · Cited by 381 · see citing works

Glycogen Synthase Kinase-3: a Putative Molecular Target for Lithium Mimetic Drugs

Gould, T. D., & Manji, H. K. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300731 · Cited by 377 · see citing works

Stress, cognitive impairment and cell adhesion molecules

Sandi, C. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1555 · Cited by 374 · see citing works

Anti-bipolar therapy: mechanism of action of lithium

Jope, R. S. (1999) · Molecular Psychiatry · doi:10.1038/sj.mp.4000494 · Cited by 371 · see citing works

The role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesis

Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00714.x · Cited by 370 · see citing works

Role of GSK3β in behavioral abnormalities induced by serotonin deficiency

Beaulieu, J.-M., Zhang, X., Rodriguiz, R. M., Sotnikova, T. D., Cools, M. J., Wetsel, W. C., Gainetdinov, R. R., & Caron, M. G. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711496105 · Cited by 368 · see citing works

Antioxidant enzyme activities and oxidative stress in affective disorders

Erkan Ozcan, M., Gulec, M., Ozerol, E., Polat, R., & Akyol, O. (2004) · International Clinical Psychopharmacology · doi:10.1097/00004850-200403000-00006 · Cited by 368 · see citing works

Glutamate neurotoxicity, oxidative stress and mitochondria

Atlante, A., Calissano, P., Bobba, A., Giannattasio, S., Marra, E., & Passarella, S. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02437-1 · Cited by 360 · see citing works

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

Maes, M. H. J. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00088-8 · Cited by 357 · see citing works

Neurons Overexpressing Heme Oxygenase‐1 Resist Oxidative Stress‐Mediated Cell Death

Chen, K., Gunter, K. K., & Maines, M. D. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750304.x · Cited by 356 · see citing works

Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy

O’Brien, S. M., Scully, P., Fitzgerald, P., Scott, L. V., & Dinan, T. G. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.05.013 · Cited by 355 · see citing works

Melatonin signaling and cell protection function

Luchetti, F., Canonico, B., Betti, M., Arcangeletti, M., Pilolli, F., Piroddi, M., Canesi, L., Papa, S., & Galli, F. (2010) · The FASEB Journal · doi:10.1096/fj.10-154450 · Cited by 343 · see citing works

Active placebos versus antidepressants for depression

Moncrieff, J., Wessely, S., & Hardy, R. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003012.pub2 · Cited by 342 · see citing works

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs

Maes, M. H. J., Delange, J., Ranjan, R., Meltzer, H. Y., Desnyder, R., Cooremans, W., & Scharpé, S. (1997) · Psychiatry Research · doi:10.1016/s0165-1781(96)02915-0 · Cited by 341 · see citing works

Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.

Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334 · see citing works

Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects

Dwivedi, Y., Rizavi, H. S., Roberts, R. C., Conley, R. C., Tamminga, C. A., & Pandey, G. N. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00300.x · Cited by 333 · see citing works

Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders

Gardner, A., & Boles, R. G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.030 · Cited by 333 · see citing works

Keap1 Controls Postinduction Repression of the Nrf2-Mediated Antioxidant Response by Escorting Nuclear Export of Nrf2

Sun, Z., Zhang, S., Chan, J. Y., & Zhang, D. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-07 · Cited by 332 · see citing works

Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system

Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H., Cass, W. A., Sullivan, P. G., & Bing, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04327.x · Cited by 322 · see citing works

Adenosine Deaminase, Nitric Oxide, Superoxide Dismutase, and Xanthine Oxidase in Patients with Major Depression: Impact of Antidepressant Treatment

Herken, H., Gurel, A., Selek, S., Armutcu, F., Ozen, M. E., Bulut, M., Kap, O., Yumru, M., Savas, H. A., & Akyol, O. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2006.10.005 · Cited by 322 · see citing works

Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells

Xia, Z., DePierre, J. W., & Nässberger, L. (1996) · Immunopharmacology · doi:10.1016/0162-3109(96)00111-7 · Cited by 318 · see citing works

NF-E2-related Factor-2 Mediates Neuroprotection against Mitochondrial Complex I Inhibitors and Increased Concentrations of Intracellular Calcium in Primary Cortical Neurons

Lee, J.-M., Shih, A. Y., Murphy, T. H., & Johnson, J. A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305204200 · Cited by 308 · see citing works

Increased Serum Levels of 8-Hydroxy-2′-Deoxyguanosine in Clinical Depression

Forlenza, M. J., & Miller, G. E. (2006) · Psychosomatic Medicine · doi:10.1097/01.psy.0000195780.37277.2a · Cited by 307 · see citing works

Mitochondrial involvement in psychiatric disorders

Shao, L., Martin, M. V., Watson, S. J., Schatzberg, A. F., Akil, H., Myers, R., Jones, E. G., Bunney, W. E., & Vawter, M. P. (2008) · Annals of Medicine · doi:10.1080/07853890801923753 · Cited by 303 · see citing works

The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?

Rosenberg, G. K. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7079-x · Cited by 301 · see citing works

In Vivo Regulation of Glycogen Synthase Kinase-3β (GSK3β) by Serotonergic Activity in Mouse Brain

Li, X., Zhu, W., Roh, M.-S., Friedman, A. B., Rosborough, K., & Jope, R. S. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300439 · Cited by 300 · see citing works

Calcium ions in neuronal degeneration

Wojda, U., Salińska, E., & Kuźnicki, J. (2008) · IUBMB Life · doi:10.1002/iub.91 · Cited by 298 · see citing works

Cytokines mediated inflammation and decreased neurogenesis in animal models of depression

Song, C., & Wang, H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.06.020 · Cited by 289 · see citing works

Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats

Xu, Y., Ku, B., Cui, L., Li, X.-J., Barish, P. A., Foster, T. C., & Ogle, W. O. (2007) · Brain Research · doi:10.1016/j.brainres.2007.05.071 · Cited by 288 · see citing works

Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease‐associated changes

Beasley, C. L., Pennington, K., Behan, Á. T., Wait, R., Dunn, M. J., & Cotter, D. (2006) · PROTEOMICS · doi:10.1002/pmic.200500069 · Cited by 284 · see citing works

Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β-catenin in mouse hippocampus

Kaidanovich‐Beilin, O., Milman, A., Weizman, A., Pick, C. G., & Eldar-Finkelman, H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.008 · Cited by 276 · see citing works

Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy

Brown, E. S., Woolston, D. J., Frol, A. B., Bobadilla, L., Khan, D. A., Hanczyc, M., Rush, A. J., Fleckenstein, J., Babcock, E. E., & Cullum, C. M. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.010 · Cited by 276 · see citing works

Lower serum vitamin E concentrations in major depression

Maes, M. H. J., Vos, N. D., Pioli, R., Demedts, P., Wauters, A., Neels, H. M., & Christophe, A. B. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00121-4 · Cited by 274 · see citing works

Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients

Gardner, A. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00067-8 · Cited by 272 · see citing works

Alterations of neuroplasticity in depression: the hippocampus and beyond

Fuchs, E., Czéh, B., Kole, M. H. P., Michaelis, T., & Lucassen, P. J. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.09.002 · Cited by 271 · see citing works

Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia

Wang, J., Shao, L., Sun, X., & Young, L. T. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00717.x · Cited by 270 · see citing works

Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats

Xu, Y., Ku, B., Yao, H.-Y., Lin, Y., Ma, X., Zhang, Y., & Li, X.-J. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.009 · Cited by 266 · see citing works

The role of GSK‐3 in synaptic plasticity

Peineau, S., Bradley, C. A., Taghibiglou, C., Doherty, A., Bortolotto, Z. A., Wang, Y. T., & Collingridge, G. L. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.2 · Cited by 263 · see citing works

STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria

Samavati, L., Rastogi, R., Du, W., Hüttemann, M., Fite, A., & Franchi, L. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.02.018 · Cited by 255 · see citing works

Heme Oxygenase-1 Couples Activation of Mitochondrial Biogenesis to Anti-inflammatory Cytokine Expression

Piantadosi, C. A., Withers, C. M., Bartz, R. R., MacGarvey, N. C., Fu, P. P., Sweeney, T. E., Welty‐Wolf, K. E., & Suliman, H. B. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.207738 · Cited by 250 · see citing works

Protection from mitochondrial complex II inhibition <i>in vitro</i> and <i>in vivo</i> by Nrf2-mediated transcription

Calkins, M. J., Jakel, R. J., Johnson, D. A., Chan, K., Kan, Y. W., & Johnson, J. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408487101 · Cited by 247 · see citing works

Administration of N‐acetylcysteine after focal cerebral ischemia protects brain and reduces inflammation in a rat model of experimental stroke

Khan, M., Sekhon, B., Jatana, M., Giri, S., Gilg, A. G., Sekhon, C., Singh, I., & Singh, A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20087 · Cited by 245 · see citing works

Cytokine Production and Serum Proteins in Depression

SEIDEL, A., AROLT, V., HUNSTIGER, M., RINK, L., BEHNISCH, A., & KIRCHNER, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03604.x · Cited by 244 · see citing works

GSK‐3β down‐regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress

Rojo, A. I., de Sagarra, M. R., & Cuadrado, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05124.x · Cited by 241 · see citing works

Multiple deletions of mitochondrial DNA in several tissues of a patient with severe retarded depression and familial progressive external ophthalmoplegia.

Suomalainen, A., Majander, A. S., Haltia, M., Somer, H., Lönnqvist, J. K., Savontaus, M. L., & Peltonen, L. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115856 · Cited by 240 · see citing works

Glycogen synthase kinase‐3β, mood stabilizers, and neuroprotection

Li, X., Bijur, G. N., & Jope, R. S. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.40201.x · Cited by 238 · see citing works

Mitochondrial dysfunction: A potential link between neuroinflammation and neurodegeneration?

Witte, M. E., Geurts, J. J. G., de Vries, H. E., van der Valk, P., & van Horssen, J. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.05.014 · Cited by 236 · see citing works

Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.

(2003) · PubMed · Cited by 236 · see citing works

Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain

Eren, İ., Nazıroğlu, M., & Demirdaş, A. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9289-x · Cited by 234 · see citing works

Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition

Rasola, A., Sciacovelli, M., Chiara, F., Pantic, B., Brusilow, W. S. A., & Bernardi, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912742107 · Cited by 225 · see citing works

Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression

Dang, H., Chen, Y., Liu, X., Wang, Q., Wang, L., Jia, W. W.-G., & Wang, Y. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.07.020 · Cited by 224 · see citing works

Glycogen synthase kinase 3: A point of convergence for the host inflammatory response

Wang, H., Brown, J. R., & Martin, M. (2010) · Cytokine · doi:10.1016/j.cyto.2010.10.009 · Cited by 215 · see citing works

Acute phase proteins in major depression

Berk, M., Wadee, A. A., Kuschke, R. H., & O’Neill-Kerr, A. (1997) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(97)00139-6 · Cited by 215 · see citing works

Neuroanatomical Pattern of Mitochondrial Complex I Pathology Varies between Schizophrenia, Bipolar Disorder and Major Depression

Ben‐Shachar, D., & Karry, R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003676 · Cited by 215 · see citing works

Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment

Gałecki, P., Szemraj, J., Bieńkiewicz, M., Florkowski, A., & Gałecka, E. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70084-2 · Cited by 214 · see citing works

Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study

Siwek, M., Dudek, D., Paul, I. A., Sowa-Kućma, M., Zięba, A., Popik, P., Pilc, A., & Nowak, G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.02.014 · Cited by 210 · see citing works

Emerging tendency towards autoimmune process in major depressive patients: A novel insight from Th17 cells

Chen, Y., Jiang, T., Chen, P., Ouyang, J., Xu, G., Zeng, Z., & Sun, Y. (2011) · Psychiatry Research · doi:10.1016/j.psychres.2010.10.029 · Cited by 209 · see citing works

Review of the Literature on Major Mental Disorders in Adult Patients With Mitochondrial Diseases

Fattal, O., Budur, K., Vaughan, A. J., & Franco, K. (2006) · Psychosomatics · doi:10.1176/appi.psy.47.1.1 · Cited by 209 · see citing works

Mitochondrial complex i subunits expression is altered in schizophrenia: a postmortem study

Karry, R., Klein, E., & Ben‐Shachar, D. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.12.012 · Cited by 208 · see citing works

Depression – emerging insights from neurobiology

Vaidya, V. A., & Duman, R. S. (2001) · British Medical Bulletin · doi:10.1093/bmb/57.1.61 · Cited by 206 · see citing works

Immune Disturbances during Major Depression: Upregulated Expression of Interleukin-2 Receptors

Maes, M. H. J., Bosmans, E., Suy, E., Vandervorst, C., Jonckheere, C. D., & Raus, J. (2008) · Neuropsychobiology · doi:10.1159/000119472 · Cited by 200 · see citing works

Oxidative Stress and Energy Crises in Neuronal Dysfunction

Nicholls, D. G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1427.002 · Cited by 199 · see citing works

Antidepressants inhibit interferon-γ-induced microglial production of IL-6 and nitric oxide

Hashioka, S., Klegeris, A., Monji, A., Kato, T., Sawada, M., McGeer, P. L., & Kanba, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.022 · Cited by 198 · see citing works

An update on regional brain volume differences associated with mood disorders

Campbell, S., & MacQueen, G. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000194371.47685.f2 · Cited by 198 · see citing works

Antioxidative enzymes and increased oxidative stress in depressive women

Kodydková, J., Vávrová, L., Zeman, M., Jirák, R., Macášek, J., Staňková, B., Tvrzická, E., & Žák, A. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.06.006 · Cited by 197 · see citing works

An assessment of the effects of central interleukin-1β, -2, -6, and tumor necrosis factor-α administration on some behavioural, neurochemical, endocrine and immune parameters in the rat

Connor, T., Song, C., Leonard, B. E., Merali, Z., & Anisman, H. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00533-2 · Cited by 195 · see citing works

A new chapter opens in anti-inflammatory treatments:The antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice

Brustolim, D., Ribeiro‐dos‐Santos, R., Kast, R. E., Altschuler, E. L., & Soares, M. B. P. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2005.12.007 · Cited by 195 · see citing works

Coenzyme Q deficiency triggers mitochondria degradation by mitophagy

Rodríguez-Hernández, Á., Cordero, M. D., Salviati, L., Artuch, R., Pineda, M., Briones, P., Izquierdo, L. G., Cotán, D., Navas, P., & Sánchez-Alcázar, J. A. (2009) · Autophagy · doi:10.4161/auto.5.1.7174 · Cited by 194 · see citing works

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics

Li, X., Rosborough, K., Friedman, A. B., Zhu, W., & Roth, K. A. (2006) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145706006547 · Cited by 191 · see citing works

Differential Regulation of STAT Family Members by Glycogen Synthase Kinase-3

Beurel, E., & Jope, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802481200 · Cited by 189 · see citing works

Treatment of Depression Is Associated With Suppression of Nonspecific and Antigen-Specific TH1 Responses in Multiple Sclerosis

Mohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001) · Archives of Neurology · doi:10.1001/archneur.58.7.1081 · Cited by 188 · see citing works

Antidepressant-like effect of trans-resveratrol: Involvement of serotonin and noradrenaline system

Xu, Y., Wang, Z., You, W., Zhang, X., Li, S., Barish, P. A., Vernon, M. M., Du, X., Li, G., & Pan, J. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.02.013 · Cited by 186 · see citing works

Anhedonic and Anxiogenic Effects of Cytokine Exposure

Anisman, H., & Merali, Z. (1999) · Advances in experimental medicine and biology · doi:10.1007/978-0-585-37970-8_12 · Cited by 185 · see citing works

In vivo antioxidant status: A putative target of antidepressant action

Zafir, A., Ara, A., & Banu, N. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.010 · Cited by 183 · see citing works

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

Berk, M., Dean, O., Cotton, S. M., Gama, C. S., Kapczinski, F., Fernandes, B. S., Kohlmann, K., Jeavons, S., Hewitt, K., Allwang, C., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.005 · Cited by 181 · see citing works

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock

Maier, S. F., & Watkins, L. R. (1995) · Brain Research · doi:10.1016/0006-8993(95)00930-o · Cited by 178 · see citing works

Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells

Jantová, S., Čipák, L., Čerňáková, M., & Košťálová, D. (2003) · Journal of Pharmacy and Pharmacology · doi:10.1211/002235703322277186 · Cited by 177 · see citing works

The role of zinc in neurodegenerative inflammatory pathways in depression

Szewczyk, B., Kubera, M., & Nowak, G. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.02.010 · Cited by 176 · see citing works

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders

Jope, R. S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00016 · Cited by 174 · see citing works

Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues

Wei, Q., Chen, W., Zhou, B., Li, Y., & Liu, Z. (2005) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.09.008 · Cited by 172 · see citing works

Mechanisms of Oxidative Glutamate Toxicity: The Glutamate/Cystine Antiporter System xc¯ as a Neuroprotective Drug Target

Albrecht, P., Lewerenz, J., Dittmer, S., Noack, R., Maher, P. A., & Methner, A. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791292567 · Cited by 172 · see citing works

The anti-inflammatory effects of ketamine: state of the art.

Loix, S., Kock, M. D., & Henin, P. (2011) · PubMed · Cited by 171 · see citing works

Activation of cell-mediated immunity in depression: Association with inflammation, melancholia, clinical staging and the fatigue and somatic symptom cluster of depression

Maes, M. H. J., Mihaylova, I., Kubera, M., & Ringel, K. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.09.006 · Cited by 170 · see citing works

Mitochondrially Mediated Plasticity in the Pathophysiology and Treatment of Bipolar Disorder

Quiroz, J. A., Gray, N. A., Kato, T., & Manji, H. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301671 · Cited by 170 · see citing works

Inhibitory Effect on Cerebral Inflammatory Response following Traumatic Brain Injury in Rats: A Potential Neuroprotective Mechanism of N‐Acetylcysteine

Chen, G., Shi, J., Hu, Z., & Hang, C. (2008) · Mediators of Inflammation · doi:10.1155/2008/716458 · Cited by 170 · see citing works

A neural cell adhesion molecule–derived peptide reduces neuropathological signs and cognitive impairment induced by Aβ25-35

Klementiev, B., Novikova, T. A., Novitskaya, V., Walmod, P. S., Dmytriyeva, O., Pakkenberg, B., Berezin, V., & Bock, E. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.060 · Cited by 166 · see citing works

The efficacy of zinc supplementation in depression: Systematic review of randomised controlled trials

Lai, J. S., Moxey, A. J., Nowak, G., Vashum, K. P., Bailey, K. A., & McEvoy, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.022 · Cited by 166 · see citing works

Total antioxidant capacity and total oxidant status in patients with major depression: Impact of antidepressant treatment

Cumurcu, B. E., Ozyurt, H., Etikan, I., Demir, S., & Karlidag, R. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.02004.x · Cited by 165 · see citing works

Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage

Bachmann, R. F., Wang, Y., Yuan, P., Zhou, R., Li, X., Alesci, S., Du, J., & Manji, H. K. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009802 · Cited by 165 · see citing works

Mitochondria-targeted antioxidants as therapies.

Smith, R. A. J., & Murphy, M. P. (2011) · PubMed · Cited by 164 · see citing works

Deconstructing GSK‐3: The Fine Regulation of Its Activity

Medina, M., & Wandosell, F. G. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/479249 · Cited by 163 · see citing works

Intestinal permeability in the pathogenesis of NSAID-induced enteropathy

Bjarnason, I., & Takeuchi, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2266-6 · Cited by 161 · see citing works

Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat

Eren, İ., Nazıroğlu, M., Demirdaş, A., Çelik, Ö., Uğuz, A. C., Altunbaşak, A., Özmen, İ., & Uz, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9258-9 · Cited by 161 · see citing works

Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness.

Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 160 · see citing works

Definition of a metal-dependent/Li(+)-inhibited phosphomonoesterase protein family based upon a conserved three-dimensional core structure.

York, J. D., Ponder, J. W., & Majerus, P. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.5149 · Cited by 159 · see citing works

Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals

Amminger, G. P., Schäfer, M. R., Klier, C. M., Slavik, J.-M., Holzer, I., Holub, M., Goldstone, S. D., Whitford, T., McGorry, P. D., & Berk, M. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.167 · Cited by 158 · see citing works

Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to DNA, in major depression and myalgic encephalomyelitis / chronic fatigue syndrome.

Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2009) · PubMed · Cited by 157 · see citing works

Potentials of Curcumin as an Antidepressant

Kulkarni, S., Dhir, A., & Akula, K. K. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.137 · Cited by 153 · see citing works

Gene expression profiles of heme oxygenase isoforms in the rat brain

Scapagnini, G., D’Agata, V., Calabrese, V., Pascale, A., Colombrita, C., Alkon, D. L., & Cavallaro, S. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03338-3 · Cited by 153 · see citing works

Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action.

Szewczyk, B., Poleszak, E., Sowa-Kućma, M., Siwek, M., Dudek, D., Ryszewska-Pokraśniewicz, B., Radziwoń-Zaleska, M., Opoka, W., Czekaj, J., Pilc, A., et al. (2008) · PubMed · Cited by 150 · see citing works

The role of IL-12 and TGF-β1 in the pathophysiology of major depressive disorder

Lee, K.-M., & Kim, Y.-K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.03.015 · Cited by 150 · see citing works

Overview of the mechanism of action of lithium in the brain: fifty-year update.

Lenox, R. H., & Hahn, C.-G. (2000) · PubMed · Cited by 149 · see citing works

Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?

Catena-Dell’Osso, M., Bellantuono, C., Consoli, G., Baroni, S., Rotella, F., & Marazziti, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794088353 · Cited by 149 · see citing works

Higher α1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: Further evidence for the existence of an inflammatory response during that illness

Maes, M. (1992) · Journal of Affective Disorders · doi:10.1016/0165-0327(92)90066-f · Cited by 147 · see citing works

Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: Markers that further explain the higher incidence of neurodegeneration and coronary artery disease

Maes, M. H. J., Mihaylova, I., Kubera, M., Uytterhoeven, M., Vrydags, N., & Bosmans, E. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.12.014 · Cited by 144 · see citing works

Lithium Prevents and Ameliorates Experimental Autoimmune Encephalomyelitis

Sarno, P. D., Axtell, R. C., Raman, C., Roth, K. A., Alessi, D. R., & Jope, R. S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.338 · Cited by 143 · see citing works

GSK-3 is a viable potential target for therapeutic intervention in bipolar disorder

Rowe, M. K., Wiest, C., & Chuang, D. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.03.002 · Cited by 142 · see citing works

Lithium‐induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue

Maurer, I., Schippel, P., & Volz, H. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00729.x · Cited by 136 · see citing works

Necrotic Cell Death in Response to Oxidant Stress Involves the Activation of the Apoptogenic Caspase-8/Bid Pathway

Wang, X., Ryter, S. W., Dai, C., Tang, Z.-L., Watkins, S. C., Yin, X.-M., Song, R., & Choi, A. M. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301624200 · Cited by 136 · see citing works

Glycogen Synthase Kinase 3: A Target for Novel Mood Disorder Treatments

Gould, T. D., & Manji, H. K. (2006) · doi:10.1002/0470052171.ch7 · Cited by 135 · see citing works

Chronic, treatment-resistant depression and right fronto-striatal atrophy

Shah, P. J., Glabus, M. F., Goodwin, G. M., & Ebmeier, K. P. (2002) · The British Journal of Psychiatry · doi:10.1192/bjp.180.5.434 · Cited by 134 · see citing works

Mitochondrial kinase signalling pathways in myocardial protection from ischaemia/reperfusion-induced necrosis

Miura, T., Tanno, M., & Sato, T. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq206 · Cited by 132 · see citing works

Functional interference between glycogen synthase kinase-3 beta and the transcription factor Nrf2 in protection against kainate-induced hippocampal celldeath

Rojo, A. I., Rada, P., Egea, J., Rosa, A. O., López, M. G., & Cuadrado, A. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.06.007 · Cited by 132 · see citing works

The Fibroblast Growth Factor System and Mood Disorders

Turner, C. A., Akil, H., Watson, S. J., & Evans, S. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.026 · Cited by 131 · see citing works

Antidepressant-like effect of the novel thiadiazolidinone NP031115 in mice

Rosa, A. O., Kaster, M. P., Binfaré, R. W., Morales, S., Martı́n-Aparicio, E., Navarro-Rico, M. L., Martı́nez, A., Medina, M., Garcı́a, A. G., López, M. G., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.05.020 · Cited by 130 · see citing works

The mechanism of lithium action: state of the art, ten years later

Shaldubina, A., Agam, G., & Belmaker, R. H. (2001) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00154-3 · Cited by 130 · see citing works

Mitochondrial Protection by Resveratrol

Ungvari, Z. I., Sonntag, W. E., de Cabo, R., Baur, J. A., & Csiszár, A. (2011) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e3182141f80 · Cited by 129 · see citing works

Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes

Macaulay, K., & Woodgett, J. (2008) · Expert opinion on therapeutic targets · doi:10.1517/14728222.12.10.1265 · Cited by 127 · see citing works

Active placebos versus antidepressants for depression (Review)

Moncrieff, J., Wessely, S. C., & Hardy, R. (2004) · UCL Discovery (University College London) · Cited by 125 · see citing works

Glycogen synthase kinase‐3 negatively regulates anti‐inflammatory interleukin‐10 for lipopolysaccharide‐induced iNOS/NO biosynthesis and RANTES production in microglial cells

Huang, W., Lin, Y., Wang, C., Tsai, C., Tseng, H., Chen, C., Lu, P., Chen, P. S., Li, Q., Hong, J., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02959.x · Cited by 124 · see citing works

Modulation of GSK-3 as a Therapeutic Strategy on Tau Pathologies

Medina, M., Garrido, J. J., & Wandosell, F. G. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00024 · Cited by 124 · see citing works

Late <i>N</i>‐acetylcysteine treatment prevents the deficits induced in the offspring of dams exposed to an immune stress during gestation

Lanté, F., Meunier, J., Guiramand, J., De Jesus Ferreira, M., Cambonie, G., Aimar, R., Cohen‐Solal, C., Maurice, T., Vignes, M., & Barbanel, G. (2008) · Hippocampus · doi:10.1002/hipo.20421 · Cited by 124 · see citing works

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients

Gałecki, P., Szemraj, J., Bieńkiewicz, M., Zboralski, K., & Gałecka, E. (2009) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.1014 · Cited by 124 · see citing works

Simvastatin Attenuates Oxidant-Induced Mitochondrial Dysfunction in Cardiac Myocytes

Jones, S. P., Teshima, Y., Akao, M., & Marbán, E. (2003) · Circulation Research · doi:10.1161/01.res.0000097262.21507.df · Cited by 124 · see citing works

Heme Induces Heme Oxygenase 1 via Nrf2

Boyle, J. J., Johns, M. S., Lo, J. W., Chiodini, A., Ambrose, N., Evans, P. C., Mason, J. C., & Haskard, D. O. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.225813 · Cited by 122 · see citing works

IgM-mediated autoimmune responses directed against multiple neoepitopes in depression: New pathways that underpin the inflammatory and neuroprogressive pathophysiology

Maes, M. H. J., Mihaylova, I., Kubera, M., Leunis, J., & Geffard, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.023 · Cited by 120 · see citing works

Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine

Valvassori, S. S., Rezin, G. T., Ferreira, C. L., Moretti, M., Gonçalves, C. L., Cardoso, M. R., STRECK, E. L., Kapczinski, F. P., & Quevedo, J. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.009 · Cited by 119 · see citing works

Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants

Tsuboi, H., Tatsumi, A., Yamamoto, K., Kobayashi, F., Shimoi, K., & Kinae, N. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.12.010 · Cited by 119 · see citing works

Increased plasma levels of 8-iso-PGF2α and IL-6 in an elderly population with depression

Dimopoulos, N., Piperi, C., Psarra, V., Lea, R. W., & Kalofoutis, A. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.019 · Cited by 118 · see citing works

Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat

Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., Kennedy, P. J., Beers, S., Scott, K., Moloney, G., et al. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.019 · Cited by 1,683 · see citing works

So depression is an inflammatory disease, but where does the inflammation come from?

Berk, M., Williams, L. J., Jacka, F. N., O’Neil, A., Pasco, J. A., Moylan, S., Allen, N. B., Stuart, A. L., Hayley, A. C., Byrne, M. L., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-200 · Cited by 1,423 · see citing works

Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls

Osimo, E. F., Pillinger, T., Rodriguez, I. M., Khandaker, G. M., Pariante, C. M., & Howes, O. D. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.02.010 · Cited by 937 · see citing works

Antioxidant and anti-inflammatory effects of zinc. Zinc-dependent NF-κB signaling

Jarosz, M., Olbert, M., Wyszogrodzka, G., Młyniec, K., & Librowski, T. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0309-4 · Cited by 740 · see citing works

Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways

Maes, M., Berk, M., Goehler, L., Song, C., Anderson, G., Gałecki, P., & Leonard, B. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-66 · Cited by 629 · see citing works

Nutritional psychiatry: The present state of the evidence

Marx, W., Moseley, G., Berk, M., & Jacka, F. (2017) · Proceedings of the Nutrition Society · doi:10.1017/s0029665117002026 · Cited by 469 · see citing works

Lifestyle medicine for depression

Sarris, J., O’Neil, A., Coulson, C. E., Schweitzer, I., & Berk, M. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-107 · Cited by 450 · see citing works

Immune mechanisms linked to depression via oxidative stress and neuroprogression

Bakunina, N., Pariante, C. M., & Zunszain, P. A. (2015) · Immunology · doi:10.1111/imm.12443 · Cited by 444 · see citing works

Oxidative & nitrosative stress in depression: Why so much stress?

Moylan, S., Berk, M., Dean, O. M., Samuni, Y., Williams, L. J., O'Neil, A. E., Hayley, A. C., Pasco, J. A., Anderson, G., Jacka, F. N., et al. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.05.007 · Cited by 401 · see citing works

Aspirin: a review of its neurobiological properties and therapeutic potential for mental illness

Berk, M., Dean, O. M., Drexhage, H. A., McNeil, J. J., Moylan, S., O'Neil, A. E., Davey, C. G., Sanna, L., & Maes, M. H. J. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-74 · Cited by 392 · see citing works

Mitochondrial Dysfunction in Depression

Bansal, Y., & Kuhad, A. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160229114755 · Cited by 355 · see citing works

Markers of Oxidative Stress and Neuroprogression in Depression Disorder

Vaváková, M., Ďuračková, Z., & Trebatická, J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/898393 · Cited by 324 · see citing works

Mitochondrial Dysfunctions in Neurodegenerative Diseases: Relevance to Alzheimer’s Disease

Hroudová, J., Singh, N., & Fišar, Z. (2014) · BioMed Research International · doi:10.1155/2014/175062 · Cited by 319 · see citing works

ROS and Brain Diseases: The Good, the Bad, and the Ugly

Popa-Wagner, A., Mitran, S., Sivanesan, S., Chang, E., & Buga, A.-M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/963520 · Cited by 427 · see citing works

Microglial Dysregulation in Psychiatric Disease

Frick, L. R., Williams, K., & Pittenger, C. (2013) · Clinical and Developmental Immunology · doi:10.1155/2013/608654 · Cited by 299 · see citing works

Maternal and Early Postnatal Nutrition and Mental Health of Offspring by Age 5 Years: A Prospective Cohort Study

Jacka, F. N., Ystrøm, E., Brantsæter, A. L., Karevold, E., Roth, C., Haugen, M. A., Meltzer, H. M., Schjølberg, S., & Berk, M. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.07.002 · Cited by 284 · see citing works

Cardiovascular disease in autoimmune rheumatic diseases

Hollan, I., Meroni, P. L., Ahearn, J. M., Tervaert, J. W. C., Curran, S., Goodyear, C. S., Hestad, K. A., Kahaleh, B., Riggio, M. P., Shields, K. J., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.03.013 · Cited by 273 · see citing works

Nrf2-dependent persistent oxidative stress results in stress-induced vulnerability to depression

Bouvier, E., Brouillard, F., Molet, J., Claverie, D., Cabungcal, J.-H., Cresto, N., Doligez, N., Rivat, C., Do, K. Q., Bernard, C., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.144 · Cited by 248 · see citing works

Cognitive remission: a novel objective for the treatment of major depression?

Bortolato, B., Miskowiak, K. W., Köhler, C. A., Maes, M., Fernandes, B. S., Berk, M., & Carvalho, A. F. (2016) · BMC Medicine · doi:10.1186/s12916-016-0560-3 · Cited by 252 · see citing works

Biological hypotheses and biomarkers of bipolar disorder

Sigitova, E., Fišar, Z., Hroudová, J., Cikánková, T., & Raboch, J. (2016) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12476 · Cited by 247 · see citing works

Antioxidants as potential therapeutics for neuropsychiatric disorders

Pandya, C. D., Howell, K. R., & Pillai, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.10.017 · Cited by 222 · see citing works

Peripheral Markers of Depression

Nobis, A., Zalewski, D., & Waszkiewicz, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123793 · Cited by 197 · see citing works

Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut–brain pathways

Martín-Subero, M., Anderson, G., Kanchanatawan, B., Berk, M., & Maes, M. H. J. (2015) · CNS Spectrums · doi:10.1017/s1092852915000449 · Cited by 196 · see citing works

The Glutathione System: A New Drug Target in Neuroimmune Disorders

Morris, G., Anderson, G., Dean, O. M., Berk, M., Gałecki, P., Martín-Subero, M., & Maes, M. H. J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8705-x · Cited by 187 · see citing works

Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectives

Finicelli, M., Squillaro, T., Cristo, F. D., Salle, A. D., Melone, M. A. B., Galderisi, U., & Peluso, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27506 · Cited by 188 · see citing works

Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatory and other cytoprotective mechanisms, is raised by health promoting factors.

Pall, M. L., & Levine, S. A. (2015) · PubMed · Cited by 184 · see citing works

Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action

Lopresti, A. L., & Drummond, P. D. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2434 · Cited by 186 · see citing works

Central pathways causing fatigue in neuro-inflammatory and autoimmune illnesses

Morris, G., Berk, M., Walder, K. R., & Maes, M. H. J. (2015) · BMC Medicine · doi:10.1186/s12916-014-0259-2 · Cited by 179 · see citing works

The relevance of oxidative stress status in first episode and recurrent depression

Stefanescu, C., & Ciobica, A. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.022 · Cited by 179 · see citing works

The role of oxidative and nitrosative stress in accelerated aging and major depressive disorder

Maurya, P. K., Noto, C. D. S., Rizzo, L. B., Rios, A. C., Nunes, S. O. V., Barbosa, D. S., Sethi, S., Zeni‐Graiff, M., Mansur, R. B., Maes, M. H. J., et al. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.08.016 · Cited by 170 · see citing works

The Efficacy of Adjunctive<i>N</i>-Acetylcysteine in Major Depressive Disorder: A Double-Blind, Randomized, Placebo-Controlled Trial

Berk, M., Dean, O. M., Cotton, S. M., Jeavons, S., Tanious, M., Kohlmann, K., Hewitt, K., Moss, K., Allwang, C., Schapkaitz, I., et al. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08454 · Cited by 172 · see citing works

Rodent Models of Depression: Neurotrophic and Neuroinflammatory Biomarkers

Stepanichev, M. Y., Дыгало, Н. Н., Grigoryan, G. A., Shishkina, G. T., & Gulyaeva, N. V. (2014) · BioMed Research International · doi:10.1155/2014/932757 · Cited by 172 · see citing works

GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression

Plátenı́k, J., Fišar, Z., Buchal, R., Jirák, R., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.001 · Cited by 159 · see citing works

Targeting IL-1 in depression

Maes, M. H. J., Song, C., & Yirmiya, R. (2012) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2012.718331 · Cited by 156 · see citing works

Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects

Lopresti, A. L., Hood, S. D., & Drummond, P. D. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112458732 · Cited by 151 · see citing works

Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications

Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 147 · see citing works

Oxidative/nitrosative stress and antidepressants: Targets for novel antidepressants

Lee, S., Lee, S.-J., Han, C., Patkar, A. A., Masand, P. S., & Pae, C. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.09.008 · Cited by 145 · see citing works

Targeting classical IL-6 signalling or IL-6<i>trans</i>-signalling in depression?

Maes, M., Anderson, G., Kubera, M., & Berk, M. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.888417 · Cited by 140 · see citing works

Molecular aspects of depression: A review from neurobiology to treatment

Boas, G. R. V., de Lacerda, R. B., Paes, M. M., Gubert, P., Almeida, W. L. D. C., Rescia, V. C., Galdino, P. M., de Carvalho, A. A. V., & Oesterreich, S. A. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.024 · Cited by 128 · see citing works

The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives

Carvalho, A. F., Berk, M., Hyphantis, T. N., & McIntyre, R. S. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000357500 · Cited by 123 · see citing works

Unfolding the Role of BDNF as a Biomarker for Treatment of Depression

Rana, T., Behl, T., Sehgal, A., Srivastava, P., & BUNGAU, S. G. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01754-x · Cited by 136 · see citing works

Effects of ginseng on stress-related depression, anxiety, and the hypothalamic–pituitary–adrenal axis

Lee, S., & Rhee, D. (2017) · Journal of Ginseng Research · doi:10.1016/j.jgr.2017.01.010 · Cited by 132 · see citing works

Honokiol abrogates lipopolysaccharide-induced depressive like behavior by impeding neuroinflammation and oxido-nitrosative stress in mice

Sulakhiya, K., Kumar, P., Jangra, A., Dwivedi, S., Hazarika, N. K., Baruah, C. C., & Lahkar, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.049 · Cited by 117 · see citing works

Pharmacological Applications of Antioxidants: Lights and Shadows

Saso, L., & Firuzi, O. (2014) · Current Drug Targets · doi:10.2174/1389450115666141024113925 · Cited by 118 · see citing works

Nrf2-signaling and BDNF: A new target for the antidepressant-like activity of chronic fluoxetine treatment in a mouse model of anxiety/depression

Mendez‐David, I., Tritschler, L., Ali, Z. E., Damiens, M.-H., Pallardy, M. J., David, D. J. P., Kerdine‐Römer, S., & Gardier, A. M. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.04.036 · Cited by 116 · see citing works

Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders

Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Bortolasci, C. C., Walder, K. R., & Berk, M. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.025 · Cited by 112 · see citing works

Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice

Freitas, A. E., Bettio, L. E. B., Neis, V. B., Santos, D. B., Ribeiro, C. M., da Rosa, P. B., Farina, M., & Rodrigues, A. L. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.012 · Cited by 108 · see citing works

Mitochondrial respiration in blood platelets of depressive patients

Hroudová, J., Fišar, Z., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.05.005 · Cited by 108 · see citing works

Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice

Freitas, A. E., Egea, J., Buendía, I., Gómez‐Rangel, V., Parada, E., Navarro, E., Casas, A. I., Wojnicz, A., Ortiz, J. A., Cuadrado, A., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9182-6 · Cited by 105 · see citing works

Evidence for Inflammation-Associated Depression

Liu, C. S., Adibfar, A., Herrmann, N., Gallagher, D., & Lanctôt, K. L. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_2 · Cited by 107 · see citing works

Putative neuroprotective agents in neuropsychiatric disorders

Dodd, S., Maes, M. H. J., Anderson, G., Dean, O. M., Moylan, S., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.11.007 · Cited by 105 · see citing works

Oxidative Stress Implications in the Affective Disorders: Main Biomarkers, Animal Models Relevance, Genetic Perspectives, and Antioxidant Approaches

Balmus, I. M., Ciobica, A., Antioch, I., Dobrin, R., & Timofte, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3975101 · Cited by 103 · see citing works

Neuroimmune mechanisms of stress: sex differences, developmental plasticity, and implications for pharmacotherapy of stress-related disease

Deak, T., Quinn, M., Cidlowski, J. A., Victoria, N. C., Murphy, A. Z., & Sheridan, J. F. (2015) · Stress · doi:10.3109/10253890.2015.1053451 · Cited by 102 · see citing works

Faster, better, stronger: Towards new antidepressant therapeutic strategies

O’Leary, O. F., Dinan, T. G., & Cryan, J. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.046 · Cited by 100 · see citing works

affron® a novel saffron extract (Crocus sativus L.) improves mood in healthy adults over 4 weeks in a double-blind, parallel, randomized, placebo-controlled clinical trial

Kell, G., Rao, A., Beccaria, G., Clayton, P., Inarejos-García, A. M., & Pródanov, M. (2017) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2017.06.001 · Cited by 98 · see citing works

Role of Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways in the Etiology of Depression: Therapeutic Implications

Anderson, G., Berk, M., Dean, O. M., Moylan, S., & Maes, M. H. J. (2013) · CNS Drugs · doi:10.1007/s40263-013-0119-1 · Cited by 93 · see citing works

The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence

Nunes, S. O. V., Vargas, H. O., Prado, E., Barbosa, D. S., de Melo, Moylan, S., Dodd, S., & Berk, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.014 · Cited by 92 · see citing works

Baicalin exerts neuroprotective effects via inhibiting activation of GSK3&bgr;/NF‐&kgr;B/NLRP3 signal pathway in a rat model of depression

Zhang, C., Zeng, M.-J., Zhou, L.-P., Li, Y.-Q., Zhao, F., Shang, Z.-Y., Deng, X.-Y., Ma, Z.-Q., Fu, Q., Ma, S.-P., et al. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.09.001 · Cited by 90 · see citing works

Inhibitory Effect of Lycopene on Amyloid-β-Induced Apoptosis in Neuronal Cells

Hwang, S., Lim, J. W., & Kim, H. (2017) · Nutrients · doi:10.3390/nu9080883 · Cited by 92 · see citing works

Protective Effects of Ascorbic Acid on Behavior and Oxidative Status of Restraint-Stressed Mice

Moretti, M., Budni, J., Santos, D. B., Antunes, A. A., Daufenbach, J. F., Manosso, L. M., Farina, M., & Rodrigues, A. L. S. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9892-4 · Cited by 92 · see citing works

Lifestyle management of unipolar depression

Berk, M., Sarris, J., Coulson, C. E., & Jacka, F. N. (2013) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12124 · Cited by 111 · see citing works

Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application

Rege, S., & Hodgkinson, S. J. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413499077 · Cited by 90 · see citing works

The Dietary Components Carnosic Acid and Carnosol as Neuroprotective Agents: a Mechanistic View

de Oliveira, M. R. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9519-1 · Cited by 92 · see citing works

Zinc in the Monoaminergic Theory of Depression: Its Relationship to Neural Plasticity

Doboszewska, U., Właź, P., Nowak, G., Radziwoń-Zaleska, M., Cui, R., & Młyniec, K. (2017) · Neural Plasticity · doi:10.1155/2017/3682752 · Cited by 89 · see citing works

Inflammatory Process and Immune System in Major Depressive Disorder

Ruiz, N. A. L., Ángel, D. S. D., Brizuela, N. O., Peraza, A. V., Olguı́n, H. J., Soto, M. P., & Guzmán, D. C. (2021) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyab072 · Cited by 85 · see citing works

Zinc in the Glutamatergic Theory of Depression

Młyniec, K. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150115220617 · Cited by 86 · see citing works

The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments

Almulla, A. F., Vasupanrajit, A., Tunvirachaisakul, C., Al‐Hakeim, H. K., Solmi, M., Verkerk, R. M., & Maes, M. H. J. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01552-4 · Cited by 78 · see citing works

Atopic disorders and depression: Findings from a large, population-based study

Sanna, L., Stuart, A. L., Pasco, J. A., Jacka, F. N., Berk, M., Maes, M. H. J., O'Neil, A. E., Girardi, P., & Williams, L. J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.009 · Cited by 84 · see citing works

Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways

Anderson, G., Maes, M. H. J., & Berk, M. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.07.016 · Cited by 83 · see citing works

Inhibition of central angiotensin II enhances memory function and reduces oxidative stress status in rat hippocampus

Bild, W., Hritcu, L., Stefanescu, C., & Ciobica, A. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.12.009 · Cited by 83 · see citing works

Keap1/Nrf2/ARE redox-sensitive signaling system as a pharmacological target

Зенков, Н. К., Брониславовна, М. Е., & Tkachev, V. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913010033 · Cited by 81 · see citing works

Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants

Martín-Hernández, D., Caso, J. R., Javier Meana, J., Callado, L. F., Madrigal, J. L. M., García-Bueno, B., & Leza, J. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1294-2 · Cited by 80 · see citing works

Adjuvant pioglitazone for unremitted depression: Clinical correlates of treatment response

Watson, K. T., Wroolie, T., Robakis, T. K., & Rasgon, N. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.10.013 · Cited by 81 · see citing works

The impact of statins on psychological wellbeing: a systematic review and meta-analysis

O'Neil, A., Sanna, L., Redlich, C., Sanderson, K., Jacka, F., Williams, L. J., Pasco, J. A., & Berk, M. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-154 · Cited by 78 · see citing works

Inflammation in psychopathology of depression: Clinical, biological, and therapeutic implications

Su, K. (2012) · Biomedicine · doi:10.1016/j.biomed.2012.03.002 · Cited by 76 · see citing works

Contributions of animal models to the study of mood disorders

Valvassori, S. S., Budni, J., Varela, R. B., & Quevedo, J. (2013) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1168 · Cited by 75 · see citing works

Multiple Immune-Inflammatory and Oxidative and Nitrosative Stress Pathways Explain the Frequent Presence of Depression in Multiple Sclerosis

Morris, G., Reiche, E. M. V., Murru, A., Carvalho, A. F., Maes, M. H. J., Berk, M., & Puri, B. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0843-5 · Cited by 74 · see citing works

Reverse cholesterol transport and lipid peroxidation biomarkers in major depression and bipolar disorder: A systematic review and meta-analysis

Almulla, A. F., Thipakorn, Y., Algon, A. A. A., Tunvirachaisakul, C., Al‐Hakeim, H. K., & Maes, M. H. J. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.08.007 · Cited by 79 · see citing works

In vitro metabolism, permeation, and brain availability of six major boswellic acids from Boswellia serrata gum resins

Gerbeth, K., Hüsch, J., Fricker, G., Werz, O., Schubert‐Zsilavecz, M., & Tawab, M. A. (2012) · Fitoterapia · doi:10.1016/j.fitote.2012.10.009 · Cited by 73 · see citing works

Connecting Dots between Mitochondrial Dysfunction and Depression

Khan, M., Baussan, Y., & Hébert-Chatelain, É. (2023) · Biomolecules · doi:10.3390/biom13040695 · Cited by 77 · see citing works

Drugs related to monoamine oxidase activity

Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 72 · see citing works

Baicalin ameliorates CUMS-induced depression-like behaviors through activating AMPK/PGC-1α pathway and enhancing NIX-mediated mitophagy in mice

Jin, X., Zhu, L., Lu, S., Li, C., Bai, M., Xu, E., Shen, J.-D., & Li, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175435 · Cited by 71 · see citing works

Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment

Schmidt, F. M., Kirkby, K. C., & Lichtblau, N. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160115130414 · Cited by 72 · see citing works

Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism

Hroudová, J., Singh, N., Fišar, Z., & Ghosh, K. K. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.084 · Cited by 71 · see citing works

The role of the GPR39 receptor in zinc deficient-animal model of depression.

Młyniec, K., Budziszewska, B., Reczynski, W., Sowa-Kućma, M., & Nowak, G. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.10.020 · Cited by 71 · see citing works

Add-on Treatment with Curcumin Has Antidepressive Effects in Thai Patients with Major Depression: Results of a Randomized Double-Blind Placebo-Controlled Study

Kanchanatawan, B., Tangwongchai, S., Sughondhabhirom, A., Suppapitiporn, S., Hemrunrojn, S., Carvalho, A. F., & Maes, M. H. J. (2018) · Neurotoxicity Research · doi:10.1007/s12640-017-9860-4 · Cited by 71 · see citing works

Antidepressant-like effect of α-tocopherol in a mouse model of depressive-like behavior induced by TNF-α

Manosso, L. M., Neis, V. B., Moretti, M., Daufenbach, J. F., Freitas, A. E., Colla, A. R. D. S., & Rodrigues, A. L. S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.06.012 · Cited by 68 · see citing works

Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice

Ludka, F. K., Constantino, L. C., Dal-Cim, T. A., Binder, L. B., Zomkowski, A. D. E., Rodrigues, A. L. S., & Tasca, C. I. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.07.004 · Cited by 66 · see citing works

A neuro-immune, neuro-oxidative and neuro-nitrosative model of prenatal and postpartum depression

Roomruangwong, C., Anderson, G., Berk, M., Stoyanov, D., Carvalho, A. F., & Maes, M. H. J. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.09.015 · Cited by 65 · see citing works

Polygenic risk score, healthy lifestyles, and risk of incident depression

Cao, Z., Yang, H., Ye, Y., Zhang, Y., Li, S., Zhao, H., & Wang, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01306-w · Cited by 64 · see citing works

Association of plant-based dietary patterns with psychological profile and obesity in Iranian women

Zamani, B., Daneshzad, E., Siassi, F., Guilani, B., Bellissimo, N., & Azadbakht, L. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2019.07.019 · Cited by 66 · see citing works

Activities of mitochondrial respiratory chain complexes in platelets of patients with Alzheimer's disease and depressive disorder

Fišar, Z., Hansíková, H., Křížová, J., Jirák, R., Kitzlerová, E., Zvěřová, M., Hroudová, J., Wenchich, L., Zeman, J., & Raboch, J. (2019) · Mitochondrion · doi:10.1016/j.mito.2019.07.013 · Cited by 63 · see citing works

Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention

Walker, A. J., Kim, Y., Price, J. B., Kale, R. P., McGillivray, J., Berk, M., & Tye, S. J. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00034 · Cited by 63 · see citing works

Agmatine Induces Nrf2 and Protects Against Corticosterone Effects in Hippocampal Neuronal Cell Line

Freitas, A. E., Egea, J., Buendía, I., Navarro, E., Rada, P., Cuadrado, A., Rodrigues, A. L. S., & López, M. G. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8827-1 · Cited by 59 · see citing works

Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant

Kokane, S. S., Armant, R. J., Bolaños‐Guzmán, C. A., & Perrotti, L. I. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112548 · Cited by 62 · see citing works

Cashew (Anacardium occidentale L.) Nuts Modulate the Nrf2 and NLRP3 Pathways in Pancreas and Lung after Induction of Acute Pancreatitis by Cerulein

Cordaro, M., Fusco, R., D’Amico, R., Siracusa, R., Peritore, A. F., Gugliandolo, E., Genovese, T., Crupi, R., Mandalari, G., Cuzzocrea, S., et al. (2020) · Antioxidants · doi:10.3390/antiox9100992 · Cited by 60 · see citing works

Effect of 25-methoxy hispidol A isolated from Poncirus trifoliate against bacteria-induced anxiety and depression by targeting neuroinflammation, oxidative stress and apoptosis in mice

Shal, B., Khan, A., Naveed, M., Khan, N. U., Ihsan‐ul‐Haq, AlSharari, S. D., Kim, Y. S., & Khan, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.047 · Cited by 58 · see citing works

Lowered PON1 activities are strongly associated with depression and bipolar disorder, recurrence of (hypo)mania and depression, increased disability and lowered quality of life

Moreira, E. G., Correia, D. G., Bonifácio, K. L., Moraes, J. B., Cavicchioli, F. L., Nunes, C. S., Nunes, S. O. V., Vargas, H. O., Barbosa, D. S., & Maes, M. H. J. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1322219 · Cited by 60 · see citing works

Ratiometric Detection of Hypochlorous Acid in Brain Tissues of Neuroinflammation and Maternal Immune Activation Models with a Deep-Red/Near-Infrared Emitting Probe

Kim, K. H., Kim, S. J., Singha, S., Yang, Y. J., Park, S. K., & Ahn, K. H. (2021) · ACS Sensors · doi:10.1021/acssensors.1c00930 · Cited by 58 · see citing works

Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression

Maes, M. H. J. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9326-6 · Cited by 55 · see citing works

New drug targets in depression: Inflammatory, cell-mediate immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. and new drug candidates-Nrf2 activators and GSK-3 inhibitors

(13320648), M. M., (18698962), Z. F., (7428344), M. M., (13330602), G. S., (13330761), G. N., & Berk, M. (2024) · Figshare

Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development?

Catena Dell'Osso, M., Bellantuono, C., Consoli, G., Baroni, S., Marazziti, D., & Rotella, F. (2011) · Florence Research (University of Florence)

Oxidative/Nitrosative Stress and Immuno-inflammatory Pathways in Depression: Treatment Implications

Anderson, G., & Maes, M. H. J. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660738 · Cited by 147 · see citing works

(Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: From antioxidants to kinase inhibitors

Maes, M. H. J., Leonard, B. E., Fernandez, A., Kubera, M., Nowak, G., Veerhuis, R., Gardner, A., Ruckoanich, P., Geffard, M., Altamura, C. A., et al. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.02.019 · Cited by 102 · see citing works

Untitled work

(2008) · PubMed · Cited by 325 · see citing works